Alice Blue - 20 years of trust
    • ANT APP
    • ANT WEB
    • 1LyAlgos
    • 1lyOptions
    • TradingView
    • MTF
    • Insurance
    • IPO
    • Stocks
    • Mutual Funds
  • Partner with us
  • Trade School
  • Pricing

    • Pricing

    About Us

    • About Us

    Calculator

    • Calculators
    • Brokerage Calculator
    • MTF Calculator

    Resources

    • Blog
    • Webinars
    • Videos (YouTube)

    Updates

    • News
    • Trading Holidays
    • Cares
    • Media Coverage
    • Disclosures

    Support

    • Support
    • Refer & Earn
    CommunityCareers
Login

    Start Investing in Stocks₹0 Account Opening

    +91
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaYes BankDSP Gold ETFAshok LeylandSuzlon EnergyTata Gold ETFTata Silver ETFBillionbrainsNHPC LtdHDFC BankMoneyviewOla ElectricPhysicswallahGTL Infra.JP Power Ven.Nip. India GoldSamvardh. Mothe.Zerodha Nifty 1D
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?
    Shares
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaYes BankDSP Gold ETFAshok LeylandSuzlon EnergyTata Gold ETFTata Silver ETFBillionbrainsNHPC LtdHDFC BankMoneyviewOla ElectricPhysicswallahGTL Infra.JP Power Ven.Nip. India GoldSamvardh. Mothe.Zerodha Nifty 1D
    Indices
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    F&O
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Mutual Funds
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    Calculators
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    IPO
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?

    Company
    • About Us
    • Work with Us
    • Terms and Conditions
    • EKYC Guidelines
    • Contact Us
    • Cares
    Apps and Products
    • ANT APP
    • ANT WEB
    • 1LYOptions
    • Trade School
    • TradingView
    • 1LyAlgos
    Calculators
    • Calculators
    • SIP Calculator
    • Mutual Funds Return Calculator
    • Brokerage Calculator
    • RMS Live Updates
    • Term Coverage Calculator
    Important Links
    • Pricing
    • KYC Tracker
    • Market News
    • Global Indices
    • Gold Rate
    • Silver Rate
    • Trading Holidays

    Alice Blue
    3rd Floor, M.R.B.Arcade, No. 153/2,
    Bagalur Main Rd, Dwarka Nagar,
    Yelahanka, Bengaluru, Karnataka
    560063
    FacebookLinkedInX (Twitter)YouTubeInstagram

    ISO 27001:2022 Alice Blue is Certified Information Security Management System (ISMS)

    ISO 22301:2019 Alice Blue is Certified Business Continuity Management System (BCMS)

    DownloadsCircularsBank DetailsLearn
    Trade on TradingViewGet it on Google PlayDownload on the App Store

    Attention Investors!
    Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.

    Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

    Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
    Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
    Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
    Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038

    COMPLIANCE OFFICER: SARAVANAN R | Mobile No: +91 91872 10670 | Email:[email protected]

    We hereby declare that we are doing PRO trading

    Procedure to file a complaint on SEBI SCORES / SMART ODR : Register on SEBI SCORES 2.0 / SMART ODR. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

    Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances. ODR Circular

    Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.

    For queries regarding account opening or activation, email to accountactivation@aliceblueindia.com and for fund updates, email to funds@aliceblueindia.com

    Disclaimer: Attention investors:1) Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. 2) Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 3) Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. 4) For demat and trading account closure with AliceBlue, kindly visit https://aliceblueonline.com/support/closure-freezing-reactivation or “ANT APPLICATION” under your profile and click on Settings -> Account Closure section -> Initiate account closure.

    No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.

    Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).

    DND PolicyInvestor CharterLegal DocumentationPrivacy policyFeedbackAnnual ReturnsAdvisory for InvestorsE-votingMandatory Member Details

    Performance

    Historical price movement and trading activity

    Trading Data

    Today's High

    746.8

    Today's Low

    726.5

    Open

    732

    Previous Close

    740.55

    Volume

    463016

    Total Traded Value High

    341599379.95

    Technicals

    Price-based indicators and levels

    Indicators

    IndicatorValueSignal
    Relative Strength Index (RSI)+60.74Neutral
    MACD-5.24Bearish

    Support and Resistance Levels

    R3769.70
    R2758.25
    R1749.40
    S1729.10
    S2717.65
    S3708.80

    Moving Averages

    PeriodSMAEMA
    20D Moving Average696.12710.13
    50D Moving Average737.98731.45
    200D Moving Average727.02732.30
    Krishna Institute of Medical Sciences Ltd

    Krishna Institute of Medical Sciences Ltd

    NSE: KIMS | BSE: 543308
    ₹731.55-9.00 (-1.22%)
    BuySell
    Trade now

    Overview

    Healthcare - Hospitals / Medical ServicesNSE / BSE

    Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004 and further upon its conversion to a Public Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It is engaged in rendering medical and healthcare services. It operate 26 multispecialty hospitals under the 'KIMS Hospitals' brand, with an aggregate capacity of over 8600 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company. Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 4000 beds, including 1,705 operational beds. The Hospitals are equipped with state-of-the-art medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4-Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India ('NABH'). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories ('NABL'). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award', by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) ('AHPI') for nursing excellence, in 2015 and for Patient Friendly Hospital', in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016. In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, post-graduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board. During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 2022-23, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 2022-23, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022; SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022. The Nagpur Hospital became functional in 2024. The Company acquired a running hospital of 200 beds-QUEENS NRI HOSPITAL in Vizag, Andhra Pradesh in Jul'24. In Kerala, the hospitals at Kannur and Kollam, commissioned in October 2024. The Company opened its first liver transplantation in Rayalaseema region in Andhra Pradesh took place in KIMS hospitals at Kurnool. Similarly, another liver transplantation took place at KIMS in Srikakulam in 2025. Company launched a 300-bed facility in Thane, Mumbai in April 2025. It launched the second unit, at Seethammadhara, with a fertility centre, Paediatric and Childcare unit and a specialty care centre. In 2026, the Company launched two super-specialty hospitals in Mahadevapura and Electronic City in Bengaluru by adding 800 beds, 30 operation theatres, more than 170 outpatient consultation rooms and 25 Centres of Excellence. At the same time, it expanded the existing network with the commissioning of a 200 bed multi-specialty facility in Kompally, Hyderabad.

    News

    Krishna Institute of Medical Sciences gains on launching QIP

    17 Jun 2026

    Krishna Institute of Medical Sciences rose 1.03% to Rs 786.20 after its Finance & Investment Committee approved the launch of a qualified institutional placement (QIP) and fixed the floor price at Rs 771.73 per equity share.

    The committee approved the opening of the issue on 16 June 2026. The floor price of Rs 771.73 per equity share is at a discount of 0.83% to the scrip's previous closing price of Rs 778.15 on the BSE. The company may offer a discount of not more than 5% on the floor price for the issue. The issue price will be determined in consultation with the bookrunning lead managers appointed for the issue. The Finance & Investment Committee is scheduled to meet on 19 June 2026 to consider and approve the issue price, including any discount thereto, in accordance with SEBI regulations. Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multidisciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at an affordable cost. The company's consolidated net profit declined 58.25% to Rs 42.50 crore despite a 34.85% increase in revenue to Rs 1,074.60 crore in Q4 FY26 over Q4 FY25. Powered by Capital Market - Live News

    KIMS to issue 77 lakh warrants worth Rs 600 crore to promoters

    13 Jun 2026

    Krishna Institute of Medical Sciences (KIMS) said that its board has approved the issuance of 77.02 lakh fully convertible warrants on a preferential basis to members of the promoter group at an issue price of Rs 779 per warrant, aggregating Rs 600 c

    Each warrant is convertible into one equity share within 18 months from the date of allotment. Of the total proposed issuance, 64.19 lakh warrants aggregating Rs 500 crore will be allotted to promoters Dr. Abhinay Bollineni and Mr. Advik Bollineni, while 12.84 lakh warrants aggregating Rs 100 crore will be allotted to promoter-group entity Bharas Ventures LLP. The proposal remains subject to shareholder approval and other regulatory clearances. The company has also scheduled an extra-ordinary general meeting (EGM) for 09 July 2026 to seek shareholder consent for the same. Assuming 100% conversion of warrants, shareholding of Dr. Abhinay Bollineni will rise to 0.84% from 0.06% currently, and that of Adwik Bollineni will climb to 0.80% from 0.01%. Bharas Ventures LLP will own 0.31% stake in the company post warrant conversion. Bharas Ventures is a limited liability partnership between the company's two promoters, viz., Dr. Bhaskara Rao Bollineni and Ms. Rajyasri Bollineni. Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The company's consolidated net profit declined 58.25% to Rs 42.50 crore despite a 34.85% increase in revenue to Rs 1,074.60 crore in Q4 FY26 over Q4 FY25. The scrip fell 2.88% to end at Rs 787.10 on the BSE on Friday. Powered by Capital Market - Live News

    KIMS gains as board to mull fundraising plan on 13 June'26

    11 Jun 2026

    Krishan Institute of Medical Science (KIMS) rose 1.31% to Rs 774.10 after the company's board is scheduled to meet on Saturday, 13 June 2026, to consider raising funds through different instruments in one or more tranches.

    The proposed fund raise may involve equity shares, fully convertible warrants, convertible or non-convertible securities, or a combination thereof through permissible modes, including a preferential issue on a private placement basis or any other approved route. Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. On consolidated basis, the company's net profit declined 58.25% to Rs 42.5 crore in Q4 FY26 from with Rs 101.8 crore in Q4 FY25. Revenue from operations increased 34.85% YoY to Rs 1,074.6 crore in Q4 FY26. Powered by Capital Market - Live News

    KIMS inks long term lease deal to establish multi-speciality hospital in Amaravati

    11 May 2026

    Krishna Institute of Medical Sciences (KIMS) has entered into a 60-year lease agreement with Andhra Pradesh Capital Region Development Authority (APCRDA) to develop 500 bedded multi-speciality hospital in Amravati, Andhra Pradesh.

    The agreement covers 2 acres of land in Amravati. The proposed multi-speciality hospital will offer comprehensive tertiary and quaternary care across cardiology, oncology, neurosciences, gastroenterology, orthopaedics, mother & child care, critical care, organ transplant and other key specialties, addressing a long-standing need for advanced healthcare infrastructure in the region. Once operational, patients in Amaravati and surrounding districts of Andhra Pradesh will gain access to high-end clinical capabilities, reducing the need of travel to other metros for specialised care. Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The company's consolidated net profit declined 39.8% to Rs 53.40 crore despite of 29.2% increase in revenue from operations to Rs 997.70 crore in Q3 FY26 over Q3 FY25. The counter advanced 1.41% to end at Rs 717.55 on the BSE. Powered by Capital Market - Live News

    Insider Activity

    Bollineni AishwaryaPromoter Group
    Disposed
    20000
    Shares Worth
    ₹4,00,00,000
    Reported On30 Dec 2023
    ModeOff Market

    Fundamentals

    Financial strength and ownership structure

    Valuation & Ratios

    Market Capitalisation

    ₹24,910.65

    Price to Book (PB)

    11.08

    Price to Earnings (PE)

    103.07

    Return on Equity (ROE)

    11.04%

    Earnings Per Share (EPS)

    6.05

    Dividend Yield

    0.00%

    Financial Performance

    605.84
    633.80
    688.40
    777.30
    772.40
    796.90
    871.60
    960.70
    997.70
    1074.60
    1179.50
    1344.40
    Dec
    '23
    Mar
    '24
    Jun
    '24
    Sep
    '24
    Dec
    '24
    Mar
    '25
    Jun
    '25
    Sep
    '25
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26

    Shareholding Pattern

    34.11%
    34.11%
    32.50%
    32.66%
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26